Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

The trial focuses on evaluating PH-762 for neoadjuvant use in Stages 1, 2, and 4 cutaneous squamous cell carcinoma, Stage 4 melanoma, and Stage 4 Merkel cell carcinoma. Importantly, no dose ...

A Phase II trial indicates that combining chemoradiotherapy with aggressive local consolidative therapy can improve survival ...